[Seite 29↓]


Alegre, M. L., Noel, P. J., Eisfelder, B. J., Chuang, E., Clark, M. R., Reiner, S. L., and Thompson, C. B. (1996). Regulation of surface and intracellular expression of CTLA4 on mouse T cells. J Immunol 157: 4762.

Allison, J.P., Chambers, C.A., Hurwitz, A., Sullivan, T.J., Boittel, B., Fournier, S., Brunner, M., and Krummel, M.F (1998). A role for CTLA-4-mediated inhibitory signals in peripheral T cell tolerance? Immunological Tolerance. Novartis Foundation. John Wiley and Sons, Inc., New York, Weinheim, Brisbane, Singapore, Toronto.

Annunziato, F., Galli, G., Cosmi, L., Romagnani, P., Manetti, R., Maggi, E., and Romagnani, S. (1998). Molecules associated with human Th1 or Th2 cells. Eur Cytokine Netw 9 : 12.

Aversa, G., Chang, C. C., Carballido, J. M., Cocks, B. G., and de Vries, J. E. (1997). Engagement of the signaling lymphocytic activation molecule (SLAM) on activated T cells results in IL-2-independent, cyclosporin A-sensitive T cell proliferation and IFN-gamma production. J Immunol 158: 4036.

Bachmann, M. F., Kohler, G., Ecabert, B., Mak, T. W., and Kopf, M. (1999). Cutting edge: lymphoproliferative disease in the absence of CTLA-4 is not T cell autonomous. J Immunol 163: 1128.

Bayrak, S., Bregulla, M., Brunner, M.C., Mitchison, N.A., and Schneider, S.C. (1995). New principles in self-tolerance and autoimmunity: First-Past-the-Post, inhibitory cytokines mediating protection by major histocompatibility complex gene, triggered by infection. Immunol Res S1: 568, S. Karger AG, Basel.

Blair, P. J., Riley, J. L., Levine, B. L., Lee, K. P., Craighead, N., Francomano, T., Perfetto, S. J., Gray, G. S., Carreno, B. M., and June, C. H. (1998). CTLA-4 ligation delivers a unique signal to resting human CD4 T cells that inhibits interleukin-2 secretion but allows Bcl-X(L) induction. J Immunol 160: 12.

Boise, L. H., Minn, A. J., Noel, P. J., June, C. H., Accavitti, M. A., Lindsten, T., and Thompson, C. B. (1995). CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. Immunity 3: 87.

Brunner, M.C., Schneider, S.C. and Mitchison, N.A. (1994). The integrative activity of the immune system. Scand J Immunol 40 : 479.

Brunner, M.C., Caput, D., Helbert, M., Mitchison, N.A., Simon, K. and Wu, P. (1992). Regulation of regulatory T-cells. Progress in Immunology 7: 627.

[Seite 30↓]

Brunner, M.C., Larsen, S., Sette, A. and Mitchison, N.A. (1996). Altered Th1/Th2 balance associated with the immunosuppressive/protective effect of the H-2Ab allele on the response to allo-4-hydroxyphenylpyruvate dioxygenase. Euro J Immunol 25 3285.

Brunner, M. C. (1999). Costimulatory molecules and modulation. The Immunologist 7: 9.

Brunner, M. C., Chambers, C. A., Chan, F. K., Hanke, J., Winoto, A., and Allison, J. P. (1999). CTLA-4-Mediated inhibition of early events of T cell proliferation. J Immunol 162: 5813.

Chambers, C. A., Krummel, M. F., Boitel, B., Hurwitz, A., Sullivan, T. J., Fournier, S., Cassell, D., Brunner, M., and Allison, J. P. (1996). The role of CTLA-4 in the regulation and initiation of T-cell responses. Immunol Rev 153: 27.

Chambers, C. A., Sullivan, T. J., Truong, T., and Allison, J. P. (1998). Secondary but not primary T cell responses are enhanced in CTLA-4- deficient CD8+ T cells. Eur J Immunol 28 : 3137.

Chen, W., Jin, W., and Wahl, S. M. (1998). Engagement of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) induces transforming growth factor beta (TGF-beta) production by murine CD4(+) T cells. J Exp Med 188: 1849.

Daniel, P. T., Kroidl, A., Cayeux, S., Bargou, R., Blankenstein, T., and Dorken, B. (1997). Costimulatory signals through B7.1/CD28 prevent T cell apoptosis during target cell lysis. J Immunol 159: 3808.

Daser, A., Mitchision, H., Mitchision, A., and B. Müller (1996). Non-classical-MHC genetics of immunological diseases in mand and mouse. The key role of pro-inflammatory cytokine genes. Cytokine 8: 593.

Del Prete, G., De Carli, M., D'Elios, M. M., Daniel, K. C., Almerigogna, F., Alderson, M., Smith, C. A., Thomas, E., and Romagnani, S. (1995). CD30-mediated signaling promotes the development of human T helper type 2-like T cells. J Exp Med 182: 1655.

Egen, J.G., and J.P. Allison (2002). CTLA-4 accumulation in the immunological synapse is regulated by TCR signal strength. Immunity 16: 23.

Egen, J.G., M.S. Kuhns, and J.P. Allison (2002). CTLA-4: new insights into its biological function and use in tumor immunotherapy. Nat Immunol 3: 611.

[Seite 31↓]

Flynn, S., Toellner, K. M., Raykundalia, C., Goodall, M., and Lane, P. (1998). CD4 T cell cytokine differentiation: the B cell activation molecule, OX40 ligand, instructs CD4 T cells to express interleukin4 and upregulates expression of the chemokine receptor, Blr-1. J Exp Med 188: 297.

Higgins, L. M., McDonald, S. A., Whittle, N., Crockett, N., Shields, J. G., and MacDonald, T. T. (1999). Regulation of T cell activation in vitro and in vivo by targeting the OX40-OX40 ligand interaction: amelioration of ongoing inflammatory bowel disease with an OX40-IgG fusion protein, but not with an OX40 ligand-IgG fusion protein. J Immunol 162: 486.

Horspool, J. H., Perrin, P. J., Woodcock, J. B., Cox, J. H., King, C. L., June, C. H., Harlan, D. M., St. Louis, D. C., and Lee, K. P. (1998). Nucleic acid vaccine-induced immune responses require CD28 costimulation and are regulated by CTLA4. J Immunol 160: 2706.

Hünig, T., and Schimpl, A. (1997). Systemic autoimmune disease as a consequence of defective lymphocyte death. Curr Opin Immunol 9, 826.

Hurtado, J. C., Kim, Y. J., and Kwon, B. S. (1997). Signals through 4-1BB are costimulatory to previously activated splenic T cells and inhibit activation-induced cell death. J Immunol 158: 2600.

Hurwitz, A. A., Sullivan, T. J., Krummel, M. F., Sobel, R. A., and Allison, J. P. (1997). Specific blockade of CTLA-4/B7 interactions results in exacerbated clinical and histologic disease in an actively-induced model of experimental allergic encephalomyelitis. J Neuroimmunol 73: 57.

Hutloff, A., Dittrich, A. M., Beier, K. C., Eljaschewitsch, B., Kraft, R., Anagnostopoulos, I., and Kroczek, R. A. (1999). ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28. Nature 397: 263.

Jacob, J., and Baltimore, D. (1999). Modelling T-cell memory by genetic marking of memory T cells in vivo. Nature 399: 593.

Kim, Y. J., Kim, S. H., Mantel, P., and Kwon, B. S. (1998). Human 4-1BB regulates CD28 co-stimulation to promote Th1 cell responses. Eur J Immunol 28 : 881.

Krummel, M. F., and Allison, J. P. (1996). CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells. J Exp Med 183: 2533.

Lakso, M., Sauer, B., Mosinger, B., Jr., Lee, E. J., Manning, R. W., Yu, S. H., Mulder, K. L., and Westphal, H. (1992). Targeted oncogene activation by site-specific recombination in transgenic mice. PNAS 89: 6232.

[Seite 32↓]

Leach, D. R., Krummel, M. F., and Allison, J. P. (1996). Enhancement of antitumor immunity by CTLA-4 blockade. Science 271: 1734.

Lee, K. M., Chuang, E., Griffin, M., Khattri, R., Hong, D. K., Zhang, W., Straus, D., Samelson, L. E., Thompson, C. B., and Bluestone, J. A. (1998). Molecular basis of T cell inactivation by CTLA-4. Science 282: 2263.

Lens, S. M., Tesselaar, K., van Oers, M. H., and van Lier, R. A. (1998). Control of lymphocyte function through CD27-CD70 interactions. Semin Immunol 10, 491.

Letterio, J. J., and Roberts, A. B. (1998). Regulation of immune responses by TGF-beta. Annu Rev Immunol 16 : 137.

Linsley, P. S., Bradshaw, J., Greene, J., Peach, R., Bennett, K. L., and Mittler, R. S. (1996). Intracellular trafficking of CTLA-4 and focal localization towards sites of TCR engagement. Immunity 4: 535.

Linsley, P. S., and Ledbetter, J. A. (1993). The role of the CD28 receptor during T cell responses to antigen. Annu Rev Immunol 11 : 191.

Luhder, F., Hoglund, P., Allison, J. P., Benoist, C., and Mathis, D. (1998). Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) regulates the unfolding of autoimmune diabetes. J Exp Med 187: 427.

Marengere, L. E., Waterhouse, P., Duncan, G. S., Mittrucker, H. W., Feng, G. S., and Mak, T. W. (1996). Regulation of T cell receptor signaling by tyrosine phosphatase SYP association with CTLA-4. Science 272: 1170.

Maszyna, F., Kunkel, D., Radbruch, A., Brunner-Weinzierl, M.C. (2003). Diversity of clonal T cell proliferation is mediated by differential expression of CTLA-4 (CTLA-4) on the cell surface of activated individual T lymphocytes J Immunol 171:3459.

McCoy, K., Camberis, M., and Gros, G. L. (1997). Protective immunity to nematode infection is induced by CTLA-4 blockade. J Exp Med 186: 183.

Moreland, L.W., Alten, R., Bosch, F., Appelboom, T., Leon, M., Emery, P., Cohen, S., Luggen, M., Shergy, W., Nuamah, I., and J.-C. Becker (2002). Costimulatory Blockade in Patients with Rheumatoid Arthritis. Arthritis and Rheumatism 46: 1470.

Moulian, N., and Berrih-Aknin, S. (1998). Fas/APO-1/CD95 in health and autoimmune disease: thymic and peripheral aspects. Semin Immunol 10: 449.

Mueller, D. L., Jenkins, M. K., and Schwartz, R. H. (1989). Clonal expansion versus functional clonal inactivation: a costimulatory signalling pathway determines the outcome of T cell antigen receptor occupancy. Annu Rev Immunol 7 : 445.

Pandiyan, P., Gärtner, D., Soezeri, O., Radbruch, A., Schulze-Osthoff, K., Brunner-Weinzierl, M.C. CTLA-4 (CTLA-4) determines the unequal resistance of Th1 and Th2 cells against activation-induced cell death by a mechanism requiring PI3´kinase function. (2004) J Exp Med. 199: 831.

Rickert, R. C., Roes, J., and Rajewsky, K. (1997). B lymphocyte-specific, Cre-mediated mutagenesis in mice. Nucleic Acids Res 25: 1317.

[Seite 33↓]

Schwartz, R. H. (1992). Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy. Cell 71, 1065.

Shiratori, T., Miyatake, S., Ohno, H., Nakaseko, C., Isono, K., Bonifacino, J. S., and Saito, T. (1997). Tyrosine phosphorylation controls internalization of CTLA-4 by regulating its interaction with clathrin-associated adaptor complex AP- 2. Immunity 6: 583.

Samson, M., Libert, F., Doranz, B.J., Rucker, J., Liesnard C., Farber, C.M., Saragosti, S, Lapoumeroulie, C., Cognaux, J., Forceille, C, Muyldermans, G, Verhofstede, C, Burtonboy, G., Georges, M., Imai, T., Rana, S., Yi Y., Smyth, R.J., Collman, R.G., Doms, R.W., Vassart, G., and M. Parmentier (1996). Resistance to HIV-1 infection in caucasian individuals bearing mutant alleles of the CCR-5 chemokine receptor gene. Nature 382: 722.

Tivol, E. A., Borriello, F., Schweitzer, A. N., Lynch, W. P., Bluestone, J. A., and Sharpe, A. H. (1995). Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3: 541.

Tivol, E. A., Boyd, S. D., McKeon, S., Borriello, F., Nickerson, P., Strom, T. B., and Sharpe, A. H. (1997). CTLA4Ig prevents lymphoproliferation and fatal multiorgan tissue destruction in CTLA-4-deficient mice. J Immunol 158, 5091.

Vinay, D. S., and Kwon, B. S. (1998). Role of 4-1BB in immune responses. Semin Immunol 10, 481.

Walunas, T. L., Bakker, C. Y., and Bluestone, J. A. (1996). CTLA-4 ligation blocks CD28-dependent T cell activation. J Exp Med 183, 2541.

Waterhouse, P., Penninger, J. M., Timms, E., Wakeham, A., Shahinian, A., Lee, K. P., Thompson, C. B., Griesser, H., and Mak, T. W. (1995). Lymphoproliferative disorders with early lethality in mice deficient in Ctla-4. Science 270: 985.

Watts, T. H., and DeBenedette, M. A. (1999). T cell co-stimulatory molecules other than CD28. Curr Opin Immunol 11: 286.

Weinberg, A. D., Vella, A. T., and Croft, M. (1998). OX-40: life beyond the effector T cell stage. Semin Immunol 10: 471.

Weiner, H. L., Gonnella, P. A., Slavin, A., and Maron, R. (1997). Oral tolerance: cytokine milieu in the gut and modulation of tolerance by cytokines. Res Immunol 148: 528.

[Seite 34↓]

Wu, Y., Guo, Y., Huang, A., Zheng, P., and Liu, Y. (1997). CTLA-4-B7 interaction is sufficient to costimulate T cell clonal expansion. J Exp Med 185: 1327.

Zheng, P., Wu, Y., Guo, Y., Lee, C., and Liu, Y. (1998). B7-CTLA4 interaction enhances both production of antitumor cytotoxic T lymphocytes and resistance to tumor challenge. PNAS 95: 6284.

© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
DiML DTD Version 3.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am: